Mariana Vieira

Mariana Vieira

Auto-generated profile, based on publicly available information

Mariana Vieira

EpiUnit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Breathe
Verified
Journal Article
Open access
PDF file
SBSara Braga
Sara Braga
MVMariana Vieira
Mariana Vieira
PBPedro Barbosa
Pedro Barbosa
JRJoão Pedro Ramos
João Pedro Ramos
RDRaquel Duarte
Raquel Duarte
Responding to a surge in new tuberculosis (TB) cases among migrants from high-incidence countries, low-incidence European nations have heeded World Health Organization recommendations by implementing TB screening in this population. This review aims to synthesise evidence on current screening strategies for active TB and latent tuberculosis infection (LTBI) in European high-income countries, and their main barriers and interventions. PubMed, Web of Science and Scopus were searched from March to April 2023, including articles in English, published in the last decade, pertaining to screening strategies for active TB or LTBI in Europe focused on migrants, excluding those exclusively composed of refugees, asylum seekers or other migrant populations. 32 studies fit the criteria. Screening in migrants varies between countries regarding timing, population, screening location and diagnosis. Furthermore, some barriers prevent migrants from benefiting from screening, namely physical, cultural and professional barriers. Additional research is needed to determine the patterns through which regular migrants adhere to current screening strategies in European countries.

1 June 2012 in Revista Gaucha de Enfermagem
Verified
Journal Article
Open access
PDF file
José Luís Guedes dos SantosJosé Luís Guedes dos Santos
José Luís Guedes dos Santos
MVMariana Vieira
Mariana Vieira
LALuciana Ferreira Cardoso Assuiti
Luciana Ferreira Cardoso Assuiti
DGDoris Gomes
Doris Gomes
BMBetina Hörner Schlindwein Meirelles
Betina Hörner Schlindwein Meirelles
SSSilvia Maria de Azevedo dos Santos
Silvia Maria de Azevedo dos Santos
The purpose of this study is to analyze the risks and vulnerability found in professional healthcare and the safe practices adopted based on academic research in the field of healthcare and nursing, by means of an integrative review. The articles were found in the LILACS and SCIELO databases,from the years 2005-2010, in a search for the descriptors vulnerability, risk, and occupational and personal health risks, establishing a sample of 21 articles. In basic healthcare, risks and vulnerabilities are related to the lack of resources needed for work, physical violence and emotional strain. In a hospital context, the problems are related to accidents with biological materials caused by improper use and failure to adopt protective measures, as well as excessive work and self-confidence. The importance of implementing public policies in worker health to improve working conditions and provide greater satisfaction and professional awareness is emphasized.

1 January 2025 in Breathe
Verified
Journal Article
Open access
SLSofia R. Lopes
Sofia R. Lopes
MMMariana Marçal
Mariana Marçal
NFNicole Fernandes
Nicole Fernandes
FSFilipa Silva
Filipa Silva
PBPedro Barbosa
Pedro Barbosa
RDRaquel Duarte
Raquel Duarte
Background: Tuberculosis (TB) remains a significant global health challenge despite ongoing control efforts, particularly in the context of drug-resistant TB (DR-TB), where treatment success rates remain low, underscoring the need for new therapeutic options. This review synthesises current evidence, since the publication of the World Health Organization guidelines in 2022, on the safety and efficacy of existing and new regimens for drug-susceptible TB (DS-TB) and DR-TB in adults and children.Methods: A comprehensive search was performed across three databases for studies published between January 2022 and February 2024, focusing on current and new TB treatment regimens. Additional backward and forward citation searches were conducted to identify relevant literature.Results: 35 studies were included, evaluating the efficacy, safety and economic impact of new oral regimens for DS-TB and DR-TB. Regimens based on bedaquiline or delamanid demonstrated high success rates and good tolerability. The BPaLM (bedaquiline, pretomanid, linezolid and moxifloxacin) regimen was more effective and safer than the standard care, while shorter DR-TB regimens reduced costs and increased success rates. However, shorter regimens for DS-TB were associated with increased drug costs. Though limited, paediatric studies suggest that shorter, safer regimens may benefit children.Conclusion: Evidence supports the adoption of shorter treatment regimens for both DR-TB and DS-TB to improve safety, effectiveness and cost-effectiveness, particularly in resource-limited settings.

3 February 2026 in Contemporary Drug Problems
Verified
Journal Article
Open access
JRJoão Pedro Ramos
João Pedro Ramos
MVMariana Vieira
Mariana Vieira
CCCátia Moreira de Carvalho
Cátia Moreira de Carvalho
FGFilipa Gonçalves
Filipa Gonçalves
PBPedro Barbosa
Pedro Barbosa
MPMarta Pinto
Marta Pinto
The rising demand for substance-related treatments results in a persistent increase in human, social, health, and economic costs that affect not only people but also reverberates across families, communities, and societies. Social environment plays a crucial role in substance use as it influences recovery pathways either by fostering drug-free behaviors or hindering them. This review aims to synthesize existing scientific evidence on the social-environmental factors that influence recovery from substance use disorders, excluding alcohol and tobacco. Following the methodological framework proposed by Arksey and O’Malley and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews, a comprehensive search was conducted in 19 databases and other sources from inception to 2024. Forty-five studies met the inclusion criteria. A multitude of social-environmental factors were shown to influence recovery such as support networks, socioeconomic conditions (i.e., housing, education, employment), spirituality, drug availability in the substance milieu, stigmatization, and the therapeutic setting. The various support networks play a key role in facilitating recovery pathways, with dysfunctional relationships and substance availability hindering recovery progress. Factors that appear to play a protective role under some circumstances could also prove to be risk factors generating feelings of loneliness and alienation. A general lack of evidence directed at post-treatment integration failed to allow an exploration of results akin to other factors. This review highlights that not a single solution appears to apply to everyone's recovery, and continued disregard for varying intersectionalities could result in the support provided being subpar to what is expected by the person involved in a change process. Therapeutic approaches to recovery should seek to be holistic and inclusive of every network by recognizing and mitigating the systemic barriers that surround those in a process of change as a means to sustain treatment's success and facilitate post-treatment integration.

15 July 2025 in Social Science & Medicine
Verified
Journal Article
Open access
MVMariana Vieira
Mariana Vieira
PBPedro Barbosa
Pedro Barbosa
JRJoão Pedro Ramos
João Pedro Ramos
MCMarta Castro
Marta Castro
DTDulce Torres
Dulce Torres
RDRaquel Duarte
Raquel Duarte
Despite global efforts to end tuberculosis (TB), slow declines in incidence and mortality rates persist, partly due to entrenched social and structural challenges. TB-related stigma is a critical barrier to effective TB prevention and treatment. However, existing frameworks often overlook broader structural and intersectional influences, underscoring the need for a comprehensive analysis of the social and structural factors influencing TB-related stigma. We aimed to (1) identify risk and protective factors influencing TB-related stigma and (2) examine how cultural, social, and economic determinants shape stigma experiences among people with TB. A systematic search was conducted across PubMed, SCOPUS, Web of Science, APA PsycInfo, and Sociology Source Ultimate. Studies were included if they (a) involved human participants, (b) were published in the last decade, and (c) reported stigma experiences influenced by social, economic, or environmental determinants. A total of 43 studies were included. Key determinants associated with higher TB-related stigma included lower educational attainment, rural residency, low income, gender, and specific mental health conditions. Cultural perceptions of TB, healthcare system interactions, and the dual stigma associated with HIV co-infection significantly exacerbated TB-related stigma experiences. Factors such as social support, patient-provider communication, and prior TB experience emerged as protective against stigma. Findings underscore TB-related stigma's complex intersection with social and structural determinants, highlighting gaps research, especially concerning standardised conceptual definitions and measurements. Addressing stigma is essential for improving TB care-seeking behaviours and health outcomes, particularly in low-resource settings where TB-related social isolation and discrimination are prevalent.

28 August 2025 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PVPedro Viegas1
Pedro Viegas1
LFLuís L Ferreira1
Luís L Ferreira1
3V3 Mariana Vieira2
3 Mariana Vieira2
PBPedro Barbosa2
Pedro Barbosa2
JRJoão Pedro Ramos
João Pedro Ramos
RDRaquel Duarte
Raquel Duarte
Objective: Personal experiences, perceptions, and views of patients are crucial in understanding the subjective impacts of diseases. The complexity and duration of tuberculosis treatment impose significant physical, emotional, social, and economic burdens, highlighting the need for person-centered, integrated care strategies that address stigma, fatigue, and accessibility to support well-being. Patient-reported outcomes (PROs) are essential for capturing patient perspectives and improving health care strategies. In this study we explored the multifaceted experiences of patients with tuberculosis, seeking to understand their values and priorities during treatment. Methods: Semistructured interviews with adult tuberculosis patients were conducted at a referral center for tuberculosis diagnosis and management in northern Portugal. After verbatim transcription and anonymization, thematic analysis was performed. Results: Seventeen interviews were conducted. Most (58.8%) of the study participants were male, and most had pulmonary tuberculosis. Our thematic analysis identified five PROs: treatment experiences; health-related quality of life; functional status; symptoms and symptom burden; and health behaviors. People with tuberculosis acknowledged the impact of multiple factors on their overall health, particularly the psychological and physical burdens of tuberculosis and its treatment. Several areas for improvement and opportunities for enhanced support were identified, particularly in communication, emotional support, and management of treatment burden. Conclusions: Our findings highlight the need for tailored PRO measures (PROMs) addressing treatment burden, psychosocial distress, and functional limitations in tuberculosis care. Enhancing communication, psychological support, and multidisciplinary approaches in tuberculosis management could improve patient outcomes and overall well-being. Addressing tuberculosis-related stigma and providing targeted interventions may contribute to a more people-centered approach to care.